Fanxiang Meng

Fanxiang Meng

Auto-generated profile, based on publicly available information

Fanxiang Meng

Department of Immunology, Basic Medicine College, China Medical University, Shenyang, Liaoning Province 110122, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
FMFanxiang Meng
Fanxiang Meng
XJXuefeng Jiang
Xuefeng Jiang
XWXiao Wang
Xiao Wang
QZQianqian Zheng
Qianqian Zheng
XWXiaonan N. Wang
Xiaonan N. Wang
XSXun Sun
Xun Sun
The binding of tumor necrosis factor–like cytokine 1A (TL1A) to death receptor 3 (DR3) plays an important role in the interaction between dendritic cells (DCs) and T cells and contributes to intestinal inflammation development. However, the mechanism by which DCs expressing TL1A mediate helper T (Th) cell differentiation in the intestinal lamina propria (LP) during the pathogenesis of inflammatory bowel disease remains unclear. In this study, we found that TL1A/DR3 promoted Th1 and Th17 cell differentiation in T-T and DC-T cell interaction-dependent manners. TL1A-deficient CD4 + T cells failed to polarize into Th1/Th17 cells and did not cause colonic inflammation in a T cell transfer colitis model. Notably, TL1A was located in the cytoplasm and nuclei of DCs, positively regulated the DC-specific ICAM-grabbing nonintegrin/RAF1/nuclear factor κB signaling pathway, enhanced the antigen uptake ability of DCs, and promoted TLR4-mediated DC activation, inducing naive CD4 + T cell differentiation into Th1 and Th17 cells. Our work reveals that TL1A plays a regulatory role in inflammatory bowel disease pathogenesis.